3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Carcinoma, Renal Cell
64
Neoplasm Metastasis
25
Kidney Neoplasms
21
Neoplasms
16
Breast Neoplasms
15
Carcinoma, Non-Small-Cell Lung
13
Urinary Bladder Neoplasms
12
Prostatic Neoplasms
10
Lung Neoplasms
8
Brain Neoplasms
8
Melanoma
7
Colorectal Neoplasms
7
Pancreatic Neoplasms
6
Ovarian Neoplasms
6
Neuroendocrine Tumors
6
Liver Neoplasms
6
Glioblastoma
6
Gastrointestinal Stromal Tumors
6
Carcinoma, Hepatocellular
6
Thyroid Neoplasms
5
Thymoma
5
Small Cell Lung Carcinoma
5
Recurrence
5
Multiple Myeloma
5
Esophageal Neoplasms
5
Carcinoma
5
Uveal Melanoma
4
Stomach Neoplasms
4
Sarcoma
4
Adenocarcinoma
4
Interventions
pembrolizumab
6
Mitotane
5
Cisplatin
5
cabozantinib
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Doxorubicin
3
sodium thiosulfate
2
relacorilant
2
cixutumumab
2
cemiplimab
2
camrelizumab
2
apatinib
2
Radiotherapy
2
Nivolumab
2
Ipilimumab
2
Etoposide
2
Cytoreduction Surgical Procedures
2
milademetan
1
lenvatinib
1
gossypol acetic acid
1
dostarlimab
1
cabazitaxel
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Vincristine
1
Tamoxifen
1
Suramin
1
Sunitinib
1
Sorafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Adrenocortical Carcinoma
×
Sunitinib
×
Clear all
NCT00453895
2019-01-31
SIRAC
University of Wuerzburg
Phase 2
Completed
39 enrolled
10 charts